• No products in the cart.
Generic selectors
Exact matches only
Search in title
Search in content
Generic selectors
Exact matches only
Search in title
Search in content
Image Alt

About Us

Cannabotech is a unique company that develops botanical-based cbd products. Our products serve anyone who wishes to adopt high quality care for the benefit of their health.

The potential of botanical CBD product

Despite the massive capital invested in healthcare solutions (US$ 4-5T/year), only 5 percent of submitted drugs reach the market.

Regulatory complexity makes it hard for the conventional healthcare industry to quickly adapt to the new way of life as we see it today.

Backed by hundreds of years of scientific endorsement, we step into a new era of agile models that produce solutions in a fast and regulated manner, to meet constantly-changing life events.

By using existing, long-known botanical resources that have been proven to be both therapeutic and safe, we can create better CBD products and swiftly reach mainstream consumers who are looking for innovative and high quality solutions.

The potential of botanical CBD product

Despite the massive capital invested in healthcare solutions (US$ 4-5T/year), only 5 percent of submitted drugs reach the market.

Regulatory complexity makes it hard for the conventional healthcare industry to quickly adapt to the new way of life as we see it today.

Backed by hundreds of years of scientific endorsement, we step into a new era of agile models that produce solutions in a fast and regulated manner, to meet constantly-changing life events.

By using existing, long-known botanical resources that have been proven to be both therapeutic and safe, we can create better CBD products and swiftly reach mainstream consumers who are looking for innovative and high quality solutions.

UPHOLDING INTEGRITY

Cannabotech is actively investing capital in CBD and mushroom research in order to advance scientific knowledge in the market. This enables us to continuously improve our products according to up-to-date research, as well as customer feedback. In addition, our products are manufactured in a current Good Manufacturing Practice (cGMP), International Organization for Standardization (ISO) certified facility.

We comply with local laws for CBD hemp extract, which dictates that legal CBD can only contain negligible trace amounts of THC (the intoxicating component of the plant) up to 0.2%. Additionally, we adhere to Medicines and Healthcare Products Regulatory Association (MHRA) and the Cosmetic, Toiletry, and Perfumery Association (CTPA) standards, including registration for novel food ingredients.

image 24

Pure CBD

Guarantee

Novel Food
Compliant

Certified

ISO 22726

Contains

botanical extracts

MHRA&CTPA
Compliant

Unique
M2CBD Formula

To further ensure the highest quality control standards, our final products are 3rd-party tested for harmful toxins.
is your Premium Partner

why cannabotech

We are a team of PhD research scientists, medical doctors, and pharmacists on a common mission to put effective, preventative care solutions into consumers’ hands. Our collective experience in academic and clinical research, pharmaceuticals and cosmetics, and medical experience ensures consumers that they can trust our evidence-based solutions for their wellbeing.

World-class professionals

Just like our solutions, the right combination of professionals is the key to success. Our team comprises experts from academic research centers, medical development, global management, and consumer retail, as well as 5 professors with extensive research in botanical ingredients and CBD, totalling 150 years of experience and proven credentials, all united to deliver the vision of the next generation CBD products based on our M2CBD formula.

Our team

CEO & Chairman

Mr. Elchanan Shaked

Founder and CEO of the Brand ‘Natural Formula, Manager of Healthcare division of Agis, Manager of Healthcare division of Perrigo ($17B), Global executive management of Perrigo, Founder of several projects in South East Asia

CSO

Dr. Efrat Oron

MSc and a PhD in Molecular Biology from Tel-Aviv University, Post-Doctoral at Yale University on embryonic stem cells, Associate Research Scientist at University of California, Scientific Advisor at the Israeli Prime Minister’s Office (“Mimshak” fellow)

CFO

Mr. Yoav Rothler

BA & MA in Economics, Long-standing experience in finance, economics and business development, Specializing in the economic planning and implementation of agro-industrial projects around the globe, Researcher in Tel-Aviv University

COO

Mr. Gadi Klarsfeld

Pharmacist with over 20 years of experience, MBA – Boston University Extensive experience in building new business units, especially pharmacies, Specializing in international consultancy for pharmacy retailers

CTO

Dr. Dov Melamed

Ph.D. in Biotechnology at Bar-Ilan University, Researcher at Bar-Ilan University’s Male Fertility Clinic and QBI, Over 15 years experience in Bio-Pharma companies, Former president of SciVac which was IPO at $300M

Scientist, Consultant & Lecturer

Prof. Yuval Heled

Ph.D., LLB, Physiologist and scientist, world-class expert in integrative physiology and physiology of effort, in the study of metabolic processes and in the prevention of disease, Professor at the Hebrew University of Jerusalem

R&D Manager

Prof. Fuad Fares

World renowned biologist and pharmacologist, Founder & director, Department of Molecular Genetics at Carmel Medical Center, Associate professor in the Department of Human Biology at Haifa University, Member of the Israel Council for Higher Education

BizDev Manager

Mr. Moav Gafni

B.Sc. in Biotechnology & Food Engineering, Extensive experience in all aspects of the Cannabis Industry: Cultivation, Marketing and Regulation

Prof. Haim Lotan
Cardio R&D

Prof. Haim Lotan

Director of Cardiology at Hadassah University Hospital, Former president of the Israel Cardiology Association, A prominent figure in the world of cardiology, Founded and directed the Israeli Department of Invasive Cardiology

Researcher

Dr. Basem Fares

Ph.D. in Oncology and Cancer Biology in the Faculty of Medicine in the Technion Institute of Technology, Cancer researcher at the Rambam Oncology Department, Research assistant in Mount Carmel Hospital and in Prolor Biotech

Prof. Tamar Peretz
Clinical Advisor

Prof. Tamar Peretz

senior physician and researcher who specializes in the treatment of breast cancer and immunological approaches in the treatment of cancer. Peretz is a full professor at the Hebrew University of Jerusalem Medical School. She previously served as director of the Sharett Institute of Oncology at Hadassah Ein Kerem Medical Center

Dr. Alex Weisman
Clinical Advisor

Dr. Alex Weisman

Former manager of R&D and BD activities at Perrigo API with Extensive experience in product selection, development of chemical analytical methods and their upscale. Alex accompanies Cannabotech in the chemical processes of developing its formulas – from conception to commercialization.